Wealthspring Capital LLC - EUROPEAN BIOTECH ACQUTN CORP ownership

EUROPEAN BIOTECH ACQUTN CORP's ticker is EBACU and the CUSIP is G3167F110. A total of 31 filers reported holding EUROPEAN BIOTECH ACQUTN CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Wealthspring Capital LLC ownership history of EUROPEAN BIOTECH ACQUTN CORP
ValueSharesWeighting
Q3 2022$680,000
-10.5%
68,613
-11.9%
0.13%
-6.3%
Q2 2022$760,000
-4.6%
77,873
-4.4%
0.14%
-8.3%
Q1 2022$797,000
-2.3%
81,483
-1.0%
0.16%
-10.9%
Q4 2021$816,000
-13.2%
82,283
-13.3%
0.18%
-22.9%
Q3 2021$940,000
+72.5%
94,900
+73.7%
0.23%
+65.7%
Q2 2021$545,000
+207.9%
54,647
+209.3%
0.14%
+185.4%
Q1 2021$177,00017,6700.05%
Other shareholders
EUROPEAN BIOTECH ACQUTN CORP shareholders Q3 2021
NameSharesValueWeighting ↓
First Trust Capital Management L.P. 210,000$2,098,0000.31%
Arena Capital Advisors, LLC- CA 225,899$2,257,0000.19%
PERISCOPE CAPITAL INC. 465,285$4,648,0000.15%
Wealthspring Capital LLC 54,647$545,0000.14%
GABELLI & Co INVESTMENT ADVISERS, INC. 65,689$657,0000.08%
Mint Tower Capital Management B.V. 100,000$999,0000.07%
Sage Mountain Advisors LLC 41,340$413,0000.07%
GLAZER CAPITAL, LLC 284,104$2,838,0000.04%
KING STREET CAPITAL MANAGEMENT, L.P. 50,000$500,0000.04%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 30,062$300,0000.04%
View complete list of EUROPEAN BIOTECH ACQUTN CORP shareholders